Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action

1 Jun 1999

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parasites and Host Interactions
Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 10480720
DOI: 10.1016/s0020-7519(99)00044-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of actionPMID 10480720Read ↗

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read ↗

Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseasesSemantic proximity Read ↗

Host-Directed Therapies for Parasitic DiseasesSemantic proximity Read ↗

Cysteine proteases: Battling pathogenic parasitic protozoans with omnipresent enzymesSemantic proximity Read ↗

Evaluation of clan CD C11 peptidase PNT1 and other Leishmania mexicana cysteine peptidases as potential drug targetsSemantic proximity Read ↗

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19Semantic proximity Read ↗

Anthelmintic drug discovery: into the future.Semantic proximity Read ↗

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.Semantic proximity Read ↗

New antibacterials for the treatment of toxoplasmosis; a patent reviewSemantic proximity Read ↗

PROTEASES IN PARASITIC DISEASESSemantic proximity Read ↗

Recent progress in the discovery of inhibitors targeting coronavirus proteasesSemantic proximity Read ↗

Emerging therapeutic targets for treatment of leishmaniasisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.